Literature DB >> 34012080

Unconventional viral gene expression mechanisms as therapeutic targets.

Jessica Sook Yuin Ho1, Zeyu Zhu1, Ivan Marazzi2,3.   

Abstract

Unlike the human genome that comprises mostly noncoding and regulatory sequences, viruses have evolved under the constraints of maintaining a small genome size while expanding the efficiency of their coding and regulatory sequences. As a result, viruses use strategies of transcription and translation in which one or more of the steps in the conventional gene-protein production line are altered. These alternative strategies of viral gene expression (also known as gene recoding) can be uniquely brought about by dedicated viral enzymes or by co-opting host factors (known as host dependencies). Targeting these unique enzymatic activities and host factors exposes vulnerabilities of a virus and provides a paradigm for the design of novel antiviral therapies. In this Review, we describe the types and mechanisms of unconventional gene and protein expression in viruses, and provide a perspective on how future basic mechanistic work could inform translational efforts that are aimed at viral eradication.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34012080     DOI: 10.1038/s41586-021-03511-5

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  177 in total

1.  Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.

Authors:  M Shehu-Xhilaga; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

Review 3.  The Tombusvirus-encoded P19: from irrelevance to elegance.

Authors:  Herman B Scholthof
Journal:  Nat Rev Microbiol       Date:  2006-05       Impact factor: 60.633

4.  The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy.

Authors:  Preetha Biswas; Xi Jiang; Annmarie L Pacchia; Joseph P Dougherty; Stuart W Peltz
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Observation of dually decoded regions of the human genome using ribosome profiling data.

Authors:  Audrey M Michel; Kingshuk Roy Choudhury; Andrew E Firth; Nicholas T Ingolia; John F Atkins; Pavel V Baranov
Journal:  Genome Res       Date:  2012-05-16       Impact factor: 9.043

6.  The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism.

Authors:  Ingeborg van Knippenberg; Charlie Carlton-Smith; Richard M Elliott
Journal:  J Gen Virol       Date:  2010-04-28       Impact factor: 3.891

7.  Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4.

Authors:  Nora McFadden; Dalan Bailey; Guia Carrara; Alicia Benson; Yasmin Chaudhry; Amita Shortland; Jonathan Heeney; Felix Yarovinsky; Peter Simmonds; Andrew Macdonald; Ian Goodfellow
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

8.  Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region.

Authors:  T Jacks; H D Madhani; F R Masiarz; H E Varmus
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

9.  Properties and abundance of overlapping genes in viruses.

Authors:  Timothy E Schlub; Edward C Holmes
Journal:  Virus Evol       Date:  2020-02-13

10.  A first look at ARFome: dual-coding genes in mammalian genomes.

Authors:  Wen-Yu Chung; Samir Wadhawan; Radek Szklarczyk; Sergei Kosakovsky Pond; Anton Nekrutenko
Journal:  PLoS Comput Biol       Date:  2007-05       Impact factor: 4.475

View more
  10 in total

1.  Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.

Authors:  Tobias Moll; Valerie Odon; Calum Harvey; Mark O Collins; Andrew Peden; John Franklin; Emily Graves; Jack Ng Marshall; Cleide Dos Santos Souza; Sai Zhang; Lydia Castelli; Guillaume Hautbergue; Mimoun Azzouz; David Gordon; Nevan Krogan; Laura Ferraiuolo; Michael P Snyder; Pamela J Shaw; Jan Rehwinkel; Johnathan Cooper-Knock
Journal:  Life Sci Alliance       Date:  2022-10-14

2.  Virus secret revealed: ribosome profiling uncovers unannotated translation initiation sites and hidden open-reading frame in the TYLCTHV genome.

Authors:  Kutubuddin A Molla
Journal:  Plant Cell       Date:  2022-04-26       Impact factor: 12.085

3.  A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19.

Authors:  Vinicius M Fava; Mathieu Bourgey; Pubudu M Nawarathna; Marianna Orlova; Pauline Cassart; Donald C Vinh; Matthew Pellan Cheng; Guillaume Bourque; Erwin Schurr; David Langlais
Journal:  Sci Adv       Date:  2022-06-01       Impact factor: 14.957

Review 4.  Insights from structural studies of the cardiovirus 2A protein.

Authors:  Neva Caliskan; Chris H Hill
Journal:  Biosci Rep       Date:  2022-01-28       Impact factor: 3.840

Review 5.  Minding the message: tactics controlling RNA decay, modification, and translation in virus-infected cells.

Authors:  Hannah M Burgess; Elizabeth I Vink; Ian Mohr
Journal:  Genes Dev       Date:  2022-02-01       Impact factor: 12.890

6.  Harnessing Rift Valley fever virus NSs gene for cancer gene therapy.

Authors:  Alicia M Davis; Tristan A Scott; Kevin V Morris
Journal:  Cancer Gene Ther       Date:  2022-04-07       Impact factor: 5.854

7.  Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.

Authors:  Tobias Moll; Valerie Odon; Calum Harvey; Mark O Collins; Andrew Peden; John Franklin; Emily Graves; Jack N G Marshall; Cleide Dos Santos Souza; Sai Zhang; Mimoun Azzouz; David Gordon; Nevan Krogan; Laura Ferraiuolo; Michael P Snyder; Pamela J Shaw; Jan Rehwinkel; Johnathan Cooper-Knock
Journal:  bioRxiv       Date:  2022-03-07

8.  Short and Sweet: Viral 5`-UTR as a Canonical and Non-Canonical Translation Initiation Switch.

Authors:  Brandon M Trainor; Natalia Shcherbik
Journal:  J Cell Immunol       Date:  2021

Review 9.  Translational Control of COVID-19 and Its Therapeutic Implication.

Authors:  Dejiu Zhang; Lei Zhu; Yin Wang; Peifeng Li; Yanyan Gao
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

10.  On the Occurrence and Multimerization of Two-Polypeptide Phage Endolysins Encoded in Single Genes.

Authors:  Daniela Pinto; Raquel Gonçalo; Mariana Louro; Marta Sousa Silva; Guillem Hernandez; Tiago N Cordeiro; Carlos Cordeiro; Carlos São-José
Journal:  Microbiol Spectr       Date:  2022-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.